These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6989366)

  • 1. The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of N-palmitoyl-cysteine and N-palmitoyl-glutamic acid alpha-methyl ester.
    Cybulla J; Brückner H; Jung G; Wipperfürth T; Bessler WG
    Biochem Biophys Res Commun; 1980 Feb; 92(4):1389-96. PubMed ID: 6989366
    [No Abstract]   [Full Text] [Related]  

  • 2. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein.
    Bessler WG; Johnson RB; Wiesmüller K; Jung G
    Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):767-70. PubMed ID: 6751983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mitogenic principle of Escherichia coli lipoprotein: B-lymphocyte mitogenicity of the synthetic analogue palmitoyl-tetrapeptide (Pam-Ser-Ser-Asn-Ala).
    Bessler WG; Cox M; Wiesmüller KH; Jung G
    Biochem Biophys Res Commun; 1984 May; 121(1):55-61. PubMed ID: 6375670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of lymphocyte populations with concanavalin A or with lipoprotein and lipopeptide from the outer cell wall of Escherichia coli: correlation of early membrane changes with induction of macromolecular synthesis.
    Resch K; Bessler W
    Eur J Biochem; 1981 Apr; 115(2):247-52. PubMed ID: 7016532
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.
    Bessler WG; Cox M; Lex A; Suhr B; Wiesmüller KH; Jung G
    J Immunol; 1985 Sep; 135(3):1900-5. PubMed ID: 3874908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli.
    Bessler W; Resch K; Hancock E; Hantke K
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):11-22. PubMed ID: 325934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological activity of the Escherichia coli lipoprotein: detection of novel lymphocyte activating peptide segments of the molecule and their conformational characterization.
    Loleit M; Deres K; Wiesmüller KH; Jung G; Eckert M; Bessler WG
    Biol Chem Hoppe Seyler; 1994 Jun; 375(6):407-12. PubMed ID: 7980873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogenicity of a lipid-deficient lipoprotein from a mutant Escherichia coli strain.
    Bessler WG; Simon E; Rotering H
    Infect Immun; 1980 Jun; 28(3):818-23. PubMed ID: 6995322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of mitogenic bacterial lipoprotein and a synthetic analogue with mouse lymphocytes. Isolation and characterization of binding proteins.
    Biesert L; Scheuer W; Bessler WG
    Eur J Biochem; 1987 Feb; 162(3):651-7. PubMed ID: 3549292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal activation of B-lymphocytes in vivo by Salmonella typhimurium lipoprotein.
    Johnson RB; Köhl S; Bessler WG
    Infect Immun; 1983 Mar; 39(3):1481-4. PubMed ID: 6341238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic analogues of the N-terminal lipid part of bacterial lipoprotein are B-lymphocyte mitogens in vitro and in vivo.
    Johnson RB; Köhl S; Wiesmüller K; Jung G; Bessler WG
    Immunobiology; 1983 Jul; 165(1):27-35. PubMed ID: 6350164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synthetic glycolipid with B-cell mitogenic activity.
    Rosenstreich DL; Asselineau J; Mergenhagen SE; Nowotny A
    J Exp Med; 1974 Nov; 140(5):1404-9. PubMed ID: 4547545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the aggregational state on the mitogenicity of lipoprotein from the outer membrane of Escherichia coli.
    Haas IG; Simon E; Bessler WG
    Immunobiology; 1980 Jan; 156(4-5):418-28. PubMed ID: 6989749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic activities of synthetic Escherichia coli lipid A and a synthetic partial structure (tripalmitoyl pentapeptide) of E. coli lipoprotein.
    Brade L; Bessler WG; Brade H
    Infect Immun; 1988 May; 56(5):1382-4. PubMed ID: 3281910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lipoprotein of the outer membrane of Escherichia coli: a B-lymphocyte mitogen.
    Melchers F; Braun V; Galanos C
    J Exp Med; 1975 Aug; 142(2):473-82. PubMed ID: 1095681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mitogenic principle of the lipoprotein from the outer membrane of Escherichia coli.
    Bessler WG; Ottenbreit BP
    Biochem Biophys Res Commun; 1976 May; 76(2):239-46. PubMed ID: 800336
    [No Abstract]   [Full Text] [Related]  

  • 17. Protein I and protein II from the outer membrane of Escherichia coli are mouse B-lymphocyte mitogens.
    Bessler WG; Henning U
    Z Immunitatsforsch Immunobiol; 1979 Jun; 155(5):387-98. PubMed ID: 382663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of the mitogenic S-[2,3-bis(palmitoyloxy)propyl]-N-palmitoylpentapeptide from Escherichia coli lipoprotein.
    Wiesmüller KH; Bessler W; Jung G
    Hoppe Seylers Z Physiol Chem; 1983 May; 364(5):593-606. PubMed ID: 6347861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments.
    Prass W; Ringsdorf H; Bessler W; Wiesmüller KH; Jung G
    Biochim Biophys Acta; 1987 Jun; 900(1):116-28. PubMed ID: 3297144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chemical approach for the localization of membrane sites involved in lymphocyte activation.
    Wynne D; Wilchek M; Novogrodsky A
    Biochem Biophys Res Commun; 1976 Feb; 68(3):730-9. PubMed ID: 177007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.